Antiretroviral Activity and Pharmacokinetics of Deferiprone in Healthy Volunteers and Asymptomatic HIV-infected Subjects
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to examine the safety, efficacy, and pharmacokinetics of
different dosages of deferiprone in subjects with or without HIV infection.